managing adverse effects complications completing treatment hepatitis virus infection pubmed ncbi abstract addition direct-acting antivirals daas hepatitis virus hcv treatment regimens made treatment effective patient management complex shepherding patients full hcv therapy requires motivation involvement part patient physician physician inexperience lack confidence guiding patients challenges treatment appears primary reason early discontinuation therapy complications hcv treatment managed efficiently effectively depression psychiatric disorders hematologic abnormalities including daa ribavirin-associated anemia peginterferon alfa-associated neutropenia thrombocytopenia rash drug eruptions including telaprevir-associated rash weight loss practical considerations management common complications offered article summarizes presentation kenneth sherman md phd ias-usa live continuing medical education held york june num 
